- Home
- ISPO vs CRIS Comparison
ISPO vs CRIS Comparison
Compare ISPO & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPO
- CRIS
- Stock Information
- Founded
- ISPO 2010
- CRIS 2000
- Country
- ISPO United States
- CRIS United States
- Employees
- ISPO N/A
- CRIS N/A
- Industry
- ISPO Blank Checks
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ISPO Finance
- CRIS Health Care
- Exchange
- ISPO Nasdaq
- CRIS Nasdaq
- Market Cap
- ISPO 39.0M
- CRIS 32.8M
- IPO Year
- ISPO N/A
- CRIS 2000
- Fundamental
- Price
- ISPO $6.99
- CRIS $3.29
- Analyst Decision
- ISPO Buy
- CRIS Strong Buy
- Analyst Count
- ISPO 2
- CRIS 3
- Target Price
- ISPO $10.50
- CRIS $23.00
- AVG Volume (30 Days)
- ISPO 71.9K
- CRIS 243.3K
- Earning Date
- ISPO 03-04-2025
- CRIS 02-06-2025
- Dividend Yield
- ISPO N/A
- CRIS N/A
- EPS Growth
- ISPO N/A
- CRIS N/A
- EPS
- ISPO N/A
- CRIS N/A
- Revenue
- ISPO $287,451,000.00
- CRIS $10,259,000.00
- Revenue This Year
- ISPO N/A
- CRIS N/A
- Revenue Next Year
- ISPO N/A
- CRIS N/A
- P/E Ratio
- ISPO N/A
- CRIS N/A
- Revenue Growth
- ISPO N/A
- CRIS 0.44
- 52 Week Low
- ISPO $3.11
- CRIS $2.86
- 52 Week High
- ISPO $9.31
- CRIS $17.49
- Technical
- Relative Strength Index (RSI)
- ISPO 87.48
- CRIS 44.97
- Support Level
- ISPO $3.26
- CRIS $3.10
- Resistance Level
- ISPO $3.75
- CRIS $3.60
- Average True Range (ATR)
- ISPO 0.49
- CRIS 0.37
- MACD
- ISPO 0.31
- CRIS 0.00
- Stochastic Oscillator
- ISPO 95.40
- CRIS 26.22
About ISPO Inspirato Incorporated
Inspirato Inc is a luxury travel subscription luxury travel company that provides exclusive access to a managed and controlled portfolio of curated vacation options, delivered through a model designed to ensure the service, certainty, and value that discerning customers demand. The Inspirato portfolio includes branded luxury vacation homes, accommodations at five-star hotel and resort partners, and custom travel experiences. It has a geographic location in the United States and Outside the United States. It generates the majority of its revenue from the United States.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.